Tuberculosis News and Research

Latest Tuberculosis News and Research

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start.

25 Feb 2014

Professor receives $17M NIH grant to support IMPAACT Network

Grace Aldrovandi, MD, CM, principal investigator at The Saban Research Institute of Children's Hospital Los Angeles, has been awarded $17 million by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

20 Feb 2014

New research may provide insight on how dengue virus gains entry into cells

Dengue fever, an infectious tropical disease caused by a mosquito-borne virus, afflicts millions of people each year, causing fever, headache, muscle and joint pains and a characteristic skin rash. In some people the disease progresses to a severe, often fatal, form known as dengue hemorrhagic fever.

18 Feb 2014

New drug patent may help overcome problems associated with MDR-TB

A chemist based at the University of Copenhagen has just taken out a patent for a drug that can make previously multidrug-resistant bacteria once again responsive to antibiotics.

18 Feb 2014

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

A large-scale survey of South African healthcare workers has revealed major gaps in workplace protection against tuberculosis, HIV and hepatitis, according to a University of British Columbia health researcher.

16 Feb 2014

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Allergy and Infectious Diseases has awarded Soligenix a Small Business Innovation Research grant to support further preclinical development of SGX943 as a treatment for melioidosis.

14 Feb 2014

Two new mechanisms open alternative approaches to antibiotics development

The first mechanism disrupts the arrangement of amino acids required for the cohesion of the protease subunits. As a result the protease breaks into two parts. The second acts directly on the core of the active center.

14 Feb 2014

Researchers examine whether spirituality has role to play in prevention of addictions

Spirituality is a central tenet of 12-step recovery programs like Alcoholics Anonymous. Its value, particularly regarding alcohol addiction, has been recognized by many health care practitioners as well.

13 Feb 2014

Drug used for treating breast cancer also kills fungal disease

Tamoxifen, a drug currently used to treat breast cancer, also kills a fungus that causes a deadly brain infection in immunocompromised patients. The findings, which could lead to new treatments for a disease that kills more HIV/AIDS patients than tuberculosis, appear in mBio-, the online open-access journal of the American Society for Microbiology (ASM.)

11 Feb 2014

Study: Rise of tuberculosis in Zimbabwe linked with widespread food shortage

The rise of tuberculosis (TB) in Zimbabwe during the socio-economic crisis of 2008-9 has been linked to widespread food shortage, according to a new study led by Canadian researchers from the University of Toronto Dalla Lana School of Public Health published in PLOS ONE.

6 Feb 2014

EGPAF expansion of HIV and AIDS treatment, prevention programs in six districts in Lesotho

The Elizabeth Glaser Pediatric AIDS Foundation is pleased to announce the expansion of its HIV and AIDS treatment and prevention programs in six districts in Lesotho.

4 Feb 2014

Vodka contributes to high death rates in Russia, new study confirms

The high and sharply fluctuating death rates in Russia are due mainly to alcohol, particularly vodka, a new prospective study of 151 000 adults confirms.

3 Feb 2014

Global atlas identifies greatest need for palliative care in low-and middle-income countries

Only 1 in 10 people who need palliative care - that is medical care to relieve the pain, symptoms and stress of serious illness - is currently receiving it. This unmet need is mapped for the first time in the "Global atlas of palliative care at the end of life", published jointly by the WHO and the Worldwide Palliative Care Alliance.

29 Jan 2014

Researchers identify unique area of human brain associated with cognitive powers

Oxford University researchers have identified an area of the human brain that appears unlike anything in the brains of some of our closest relatives.

29 Jan 2014

Scientists produce new version of old antibiotic that is active against difficult-to-treat tuberculosis

St. Jude Children's Research Hospital scientists have discovered a promising new class of antibiotics that could aid efforts to overcome drug-resistance in tuberculosis (TB), a global killer.

28 Jan 2014

New versions of old antibiotic offers strategy for overcoming drug resistance

Research led by St. Jude Children's Research Hospital scientists has produced new versions of an old antibiotic that are active against difficult-to-treat tuberculosis; offers new strategy for overcoming drug resistance

28 Jan 2014

Study finds new class of semisynthetic anti-tuberculosis agents that overcome native drug efflux

Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have developed a method to synthesize modified forms of an established antibiotic called spectinomycin.

27 Jan 2014

NIBIO signs collaboration agreement for clinical development of new mucosal TB vaccines

Japan's National Institute of Biomedical Innovation ("NIBIO"), Aeras and Create Vaccine Company, Ltd ("CREATE") announce today that they signed a collaboration agreement on December 26, 2013, on the preclinical and clinical development of new mucosal tuberculosis (TB) vaccines based on NIBIO's human parainfluenza type-2 (rhPIV2) vector technology.

27 Jan 2014

Medicaid 'death debt' causes some to step away from coverage

A little-known aspect of Medicaid allows states, in certain cases, to recoup medical costs by claiming deceased people's homes, which is causing some people to avoid coverage, even those who are newly eligible under the health law's expanded eligibility.

24 Jan 2014

Xpert MTB/RIF test quickly detects TB and resistance to rifampicin

A second systematic review of a diagnostic test for tuberculosis (TB) endorsed by the World Health Organisation (WHO), has confirmed the accuracy of the test. The updated review assessing the accuracy of Xpert MTB/RIF includes new studies published since the original Cochrane Review was published in January last year.

22 Jan 2014

Tuberculosis News and Research

Latest Tuberculosis News and Research

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

Professor receives $17M NIH grant to support IMPAACT Network

New research may provide insight on how dengue virus gains entry into cells

New drug patent may help overcome problems associated with MDR-TB

Major gaps persist in workplace protection against TB, HIV and hepatitis in South Africa

NIAID awards Soligenix SBIR grant to further develop SGX943 for treatment of melioidosis

Two new mechanisms open alternative approaches to antibiotics development

Researchers examine whether spirituality has role to play in prevention of addictions

Drug used for treating breast cancer also kills fungal disease

Study: Rise of tuberculosis in Zimbabwe linked with widespread food shortage

EGPAF expansion of HIV and AIDS treatment, prevention programs in six districts in Lesotho

Vodka contributes to high death rates in Russia, new study confirms

Global atlas identifies greatest need for palliative care in low-and middle-income countries

Researchers identify unique area of human brain associated with cognitive powers

Scientists produce new version of old antibiotic that is active against difficult-to-treat tuberculosis

New versions of old antibiotic offers strategy for overcoming drug resistance

Study finds new class of semisynthetic anti-tuberculosis agents that overcome native drug efflux

NIBIO signs collaboration agreement for clinical development of new mucosal TB vaccines

Medicaid 'death debt' causes some to step away from coverage

Xpert MTB/RIF test quickly detects TB and resistance to rifampicin

Pharmaceutical Manufacturing - Industry Focus eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Tuberculosis News and Research

Latest Tuberculosis News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in